Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intermittent maple syrup urine disease (intermittent MSUD) is a mild form of MSUD where patients (when well) are asymptomatic with normal levels of branched-chain amino acids (BCAAs) but with catabolic stress are at risk of acute decompensation with ketoacidosis, which can lead to cerebral edema and coma if untreated.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for intermittent maple syrup urine disease.
1 publication has been identified in PubMed for intermittent maple syrup urine disease. Research spans Case Report / Case Series (100%).
Upadia J (2025). [PMID: 40823510](https://pubmed.ncbi.nlm.nih.gov/40823510/). *Molecular genetics and metabolism reports*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:53 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center